ClinicalTrials.gg
CompletedNCT07788508MCR-MidwivesUpdated Aug 28, 2026

Mandala Coloring and Resilience in Midwives

An interventional study of Mandala Coloring in Psychological Resilience Among Midwives Working in Delivery Rooms, sponsored by Istanbul University - Cerrahpasa. Completed at 8 sites in Turkey (Türkiye). Open to female participants, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-28.

Sponsored by Istanbul University - Cerrahpasa · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Registered 1 year 7 months after the study started (first participant enrolled Jan 2025, registered Aug 2026).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
91
Allocation
Randomized
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-13

Among 340 studies in Depression with a site in Turkey — 59 open to participants now, 70 under way, none of them phase 3. Depression · Turkey.

Enrollment
60th of 244
91 · median 60
Started
2025
with 58 others
No phase
237 of 340
43 open now
Registered
316th of 340
by date
Lead sponsor
6 of 340
Istanbul University - Cerrahpasa

Among the 340 studies in Depression with a site in Turkey, this one is the 60th largest by enrollment of the 244 interventional ones that give a count, is one of 59 that started in 2025, is one of 237 with no phase, and was the 316th registered.

Depression

8,582 studies on the registry are indexed under Depression; 1,723 are open to participants now.

Browse Depression studies →

Open to participants now

59 of the 340 studies in Depression with a site in Turkey are open now. Recruiting first, the newest first:

54 more — sign in →

All 59 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 1,089 Depression studies recruiting now, 470 (43%) set no upper age limit and 519 (48%) stop at 75 or younger; 203 take children under 18; 311 take healthy volunteers.

This study: female · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 340 studies in Depression with a site in Turkey, or all of them as a file.
02

Study summary

Midwives working in delivery rooms are exposed to occupational and psychological stressors associated with high workloads, shift work, time pressure, obstetric emergencies, and traumatic perinatal events. These working conditions may adversely affect their psychological resilience and well-being. Mandala coloring is a simple, low-cost, art-based activity that may promote relaxation and psychological well-being; however, evidence regarding its effect on psychological resilience among midwives is limited.

The aim of this study was to evaluate the effect of mandala coloring on psychological resilience among midwives working in delivery rooms. Secondary outcomes included depression, anxiety, stress, and psychological well-being.

The study was conducted as a two-arm, pretest-posttest, matched cluster randomized controlled trial involving midwives working in the delivery rooms of eight hospitals. Hospitals were treated as clusters and matched into four pairs according to the number of midwives working in the delivery room and the annual number of births. Within each matched pair, one hospital was randomly assigned to the intervention group and the other to the control group. A total of 91 midwives participated in the study, with 45 midwives from four hospitals allocated to the intervention group and 46 midwives from four hospitals allocated to the control group.

Midwives in the intervention group participated in a six-week mandala coloring program. They were asked to complete two mandala coloring sessions per week, for a total of 12 sessions, with each session lasting approximately 20-30 minutes. Participants in the control group continued their usual routines during the six-week study period.

Psychological resilience was assessed as the primary outcome using the Resilience Scale for Adults. Depression, anxiety, and stress were assessed using the Depression Anxiety Stress Scale-21, and psychological well-being was assessed using the Psychological Well-Being Scale. Outcomes were assessed at baseline and at the end of the six-week intervention period.

Read the detailed description

Midwives working in delivery rooms may be exposed to substantial occupational and psychological stressors due to high workloads, shift work, time pressure, obstetric emergencies, and exposure to traumatic perinatal events. These demands may adversely affect their psychological well-being and resilience. Psychological resilience is particularly important for midwives because it may support their ability to adapt to stressful working conditions while maintaining professional functioning and well-being.

Art-based activities have been investigated as non-pharmacological approaches for reducing psychological distress and promoting well-being. Mandala coloring is a structured art-based activity involving the coloring of repetitive and geometric patterns. It is inexpensive, easy to implement, requires minimal resources, and can potentially be incorporated into workplace settings without extensive training.

Previous studies have suggested that mandala-based interventions may have beneficial effects on outcomes such as stress, anxiety, psychological well-being, and coping in different populations. However, evidence regarding the effect of mandala coloring specifically on psychological resilience remains limited and inconsistent. Furthermore, there is limited evidence evaluating mandala coloring as a workplace-based intervention among midwives working in delivery rooms.

This study was therefore designed to evaluate whether a six-week mandala coloring intervention could improve psychological resilience among midwives working in delivery rooms. The study also examined the effects of the intervention on depression, anxiety, stress, and psychological well-being as secondary outcomes. By evaluating a simple, low-cost, and easily applicable intervention within the clinical work environment, the study aimed to contribute evidence regarding strategies that may support the psychological well-being of midwives.

03

Conditions studied

  • Psychological Resilience Among Midwives Working in Delivery Rooms

Keywords

  • Psychological resilience
  • Mandala coloring
  • Midwives
  • Delivery room
  • depression
  • anxiety
  • stress
04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Working as a midwife in the delivery room of one of the participating hospitals
  • Voluntarily agreeing to participate in the study
  • Providing

Exclusion criteria

Exclusion Criteria:

  • Having difficulty communicating in Turkish or having a hearing, speech, or comprehension impairment that could interfere with communication and participation in the study
  • Having a physical or visual impairment that could prevent participation in the mandala coloring activity
  • Having a psychiatric disorder
  • Routinely engaging in stress-reduction or relaxation practices, such as meditation or yoga
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
91 participants (actual)

Study arms

  • Experimental
    Mandala Coloring Group

    Participants in this arm completed a six-week mandala coloring intervention. They were instructed to color a mandala twice per week for approximately 20-30 minutes per session, resulting in a total of 12 planned sessions. Participants selected a mandala design and colored it according to their own preferences. Adherence was monitored by asking participants to notify the researcher before each session and to send a photograph of the completed mandala after each session. Reminder messages were sent twice weekly.

    Behavioral: Mandala Coloring

  • No intervention
    Control Group

    Participants in this arm continued their usual routines and did not receive the mandala coloring intervention during the six-week study period. They were contacted twice weekly to determine whether they had engaged in any relaxation or stress-reducing activities during the study period. After completion of the final assessment, participants were provided with information about mandala coloring and were offered the opportunity to engage in the activity.

Interventions

  • BehavioralMandala Coloring

    Participants completed mandala coloring twice per week for six consecutive weeks, for a total of 12 sessions. Each session lasted approximately 20-30 minutes and was conducted during working hours at a time suitable for the participant. Participants selected one of the provided mandala designs and colored it according to their own preferences using a 12-color felt-tip pen set. Adherence was monitored through messages sent before each session and photographs of the completed mandalas sent to the researcher after each session. Reminder messages were sent twice weekly.

06

What researchers measure

Primary outcomes

  1. Resilience Scale for Adults (RSA)

    Psychological resilience was assessed using the Resilience Scale for Adults (RSA). The scale consists of 33 items and yields a total score ranging from 33 to 165. Higher scores indicate higher levels of psychological resilience. The primary outcome was the change in the total RSA score from baseline to the end of the six-week intervention.

    Time frame: Baseline and immediately after the 6-week intervention

Secondary outcomes

  1. Depression Anxiety Stress Scale-21 (DASS-21)

    The scale is a 21-item self-report instrument used to assess symptoms of depression, anxiety, and stress. It consists of three sub-dimensions: depression, anxiety, and stress, with seven items in each sub-dimension. Items are rated from 0 to 3, with a raw score ranging from 0 to 21 for each sub-dimension. Higher scores indicate a higher level of depression, anxiety, or stress symptoms in that sub-dimension.

    Time frame: Baseline and immediately after the 6-week intervention

  2. Psychological Well-Being Scale

    Psychological well-being was assessed using the 8-item Psychological Well-Being Scale. Total scores range from 8 to 56, with higher scores indicating greater psychological well-being.

    Time frame: Baseline and immediately after the 6-week intervention

07

Study locations

8 sites
  • Medipol Bahçelievler Üniversity Hospital
    Istanbul, Bahçelievler, Turkey (Türkiye)
  • Medipol Mega Üniversity Hospital
    Istanbul, Bağcılar, Turkey (Türkiye)
  • Medipol Esenler Üniversity Hospital
    Istanbul, Esenler, Turkey (Türkiye)
  • MEDIPOL Acıbadem Regional Hospital
    Istanbul, Kadıköy, Turkey (Türkiye)
  • Medipol Koşuyolu Hospital
    Istanbul, Kadıköy, Turkey (Türkiye)
  • Medipol Sefaköy Üniversity Hospital
    Istanbul, Küçükçekmece, Turkey (Türkiye)
  • Medipol Pendik Üniversity Hospital
    Istanbul, Pendik, Turkey (Türkiye)
  • Medipol Çamlıca Üniversity Hospital
    Istanbul, Uskudar, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No — Data are available from the corresponding author upon reasonable request

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jan 2025 to primary completion in Aug 2025, 7 months.

Of 3,471 non-industry interventional studies with no phase under Depression, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 41. This study's 7 months is below that.

Counting every sponsor, half of 3,569 studies reached it within 21 months; a quarter within 9 and three quarters within 41.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 23, 2026
First posted
Aug 26, 2026
StartActual
Jan 1, 2025
Primary completionActual
Aug 30, 2025
CompletionActual
Aug 30, 2025
Last update
Aug 28, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 28, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07788508
Responsible party
Neriman Guducu (Assistant Professor, Istanbul University - Cerrahpasa) — Principal investigator
First posted
Aug 26, 2026
Start date
Jan 1, 2025
Primary completion
Aug 30, 2025
Completion
Aug 30, 2025
Last update
Aug 28, 2026

Study contacts

Neriman Güdücü, Ph.D.
principal investigator · Istanbul University - Cerrahpasa

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion